Shigemoto Eiji, Iwata Atsushi, Futami Makito, Kato Yuta, Yamashita Motoki, Imaizumi Satoshi, Kuwano Takashi, Ike Amane, Sugihara Makoto, Saku Keijiro, Miura Shin-Ichiro
Department of Cardiology, Fukuoka University School of Medicine, 7-45-1 Nanakuma Jonan-ku, Fukuoka, 814-0180, Japan.
Department of Clinical Research and Ethics Center, Fukuoka University School of Medicine, Fukuoka, Japan.
Heart Vessels. 2019 Jul;34(7):1065-1075. doi: 10.1007/s00380-018-01334-5. Epub 2019 Jan 3.
Chronic kidney disease (CKD) is well known to be associated with an increased incidence of coronary artery disease (CAD). Diabetes mellitus (DM) and hypertension (HTN), both of which are traditional risk factors for CAD, are the two most common causes of CKD. However, the influence of CKD on coronary atherosclerosis in CAD patients who have both DM and HTN remains uncertain. In these patients, we examined the relationship between CKD and coronary plaque using integrated backscatter intravascular ultrasound (IB IVUS). Two hundred two CAD patients with both DM and HTN who underwent percutaneous coronary intervention using IB IVUS were included. The patients were divided into two groups: CKD group (n = 106) and non-CKD group (n = 96). Gray-scale and IB IVUS examinations were conducted for the non-culprit segment of a coronary artery. As a result, although there was no significant difference in the percentage of plaque volume, the percentage of lipid volume was significantly higher in the CKD group than in the non-CKD group [median (IQR): 56.7% (45.4-67.0%) vs. 52.0% (38.3-60.2%), p = 0.03]. In all of the patients, estimated glomerular filtration rate levels were negatively correlated with the percentage of lipid volume (r = - 0.15, p = 0.03) and positively correlated with the percentage of fibrosis volume (r = 0.15, p = 0.04). A multivariate regression analysis showed that CKD was an independent predictor associated with the increased lipid volume (β = 0.15, p = 0.047) and decreased fibrosis volume (β = - 0.16, p = 0.03) in coronary plaques. In conclusion, among CAD patients who had both DM and HTN, CKD was associated with lipid-rich coronary plaques. CKD may contribute to the vulnerability of coronary plaque in these very high-risk patients.
众所周知,慢性肾脏病(CKD)与冠状动脉疾病(CAD)发病率增加有关。糖尿病(DM)和高血压(HTN)是CAD的两个传统危险因素,也是CKD最常见的两个病因。然而,CKD对同时患有DM和HTN的CAD患者冠状动脉粥样硬化的影响仍不明确。在这些患者中,我们使用背向散射积分血管内超声(IB-IVUS)研究了CKD与冠状动脉斑块之间的关系。纳入了202例同时患有DM和HTN并接受IB-IVUS引导下经皮冠状动脉介入治疗的CAD患者。将患者分为两组:CKD组(n = 106)和非CKD组(n = 96)。对冠状动脉非罪犯节段进行灰阶和IB-IVUS检查。结果显示,虽然斑块体积百分比无显著差异,但CKD组脂质体积百分比显著高于非CKD组[中位数(四分位间距):56.7%(45.4 - 67.0%)对52.0%(38.3 - 60.2%),p = 0.03]。在所有患者中,估算肾小球滤过率水平与脂质体积百分比呈负相关(r = -0.15,p = 0.03),与纤维化体积百分比呈正相关(r = 0.15,p = 0.04)。多因素回归分析显示,CKD是冠状动脉斑块脂质体积增加(β = 0.15,p = 0.047)和纤维化体积减少(β = -0.16,p = 0.03)的独立预测因素。总之,在同时患有DM和HTN的CAD患者中,CKD与富含脂质的冠状动脉斑块有关。CKD可能促使这些高危患者的冠状动脉斑块易损。